Skip to main content

Advertisement

Log in

PlGF gene knockdown in human retinal pigment epithelial cells

  • Basic Science
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

Background

To evaluate the knockdown of placental growth factor (PlGF) gene expression in human retinal pigment epithelium (RPE) cells and its effect on cell proliferation, apoptosis and angiogenic potential of RPE cells.

Methods

Human RPE cells were isolated by dispase I solution and cultured in DMEM/F12 supplemented with 10% fetal calf serum (FCS). A small interfering RNA (siRNA) corresponding to PlGF mRNA and a scrambled siRNA (scRNA) were introduced into the cells. Cell proliferation and cell death were examined by ELISA. PlGF mRNA and protein were quantified by real-time polymerase chain reaction (PCR) and western blot. The levels of gene expression for human retinal pigment epithelium-specific protein 65 kDa (RPE65), cellular retinaldehyde-binding protein (CRALBP) and tyrosinase were examined by real-time PCR. The angiogenic activity of RPE cell-derived conditioned media was assayed by a tube formation assay using human umbilical vein endothelial cells (HUVECs).

Results

At a final siRNA concentration of 20 pmol/ml, the transfection efficiency was about 80%. The amount of PlGF transcripts was reduced to 10% after 36 h of incubation, and the amount of PlGF protein in culture supernatant was significantly decreased. Suppression of PlGF gene had no effect on RPE cell proliferation and survival, and there were no notable changes in the transcript levels of RPE65, CRALBP or tyrosinase for the cultures treated by siRNA cognate to PlGF. Vascular tube formation was efficiently reduced in HUVECs.

Conclusions

Our findings present PlGF as a key modulator of angiogenic potential in RPE cells of the human retina.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  1. Klimanskaya I (2006) Retinal pigment epithelium. Meth Enzymol 418:169–194

    Article  PubMed  CAS  Google Scholar 

  2. Spilsbury K, Garrett KL, Shen WY, Constable IJ, Rakoczy PE (2000) Overexpression of vascular endothelial growth factor (VEGF) in the retinal pigment epithelium leads to the development of choroidal neovascularization. Am J Pathol 157:135–144

    Article  PubMed  CAS  Google Scholar 

  3. Witmer AN, Vrensen GFJ, Noorden V, Schlingemann RO (2003) Vascular endothelial growth factors and angiogenesis in eye disease. Prog Retin Eye Res 22:1–29

    Article  PubMed  CAS  Google Scholar 

  4. Ferrara N (2004) Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 25:581–611

    Article  PubMed  CAS  Google Scholar 

  5. Cashman SM, Bowman L, Christofferson J, Kumar-Singh R (2006) Inhibition of choroidal neovascularization by adenovirus-mediated delivery of short hairpin RNAs targeting VEGF as a potential therapy for AMD. Invest Ophthalmol Vis Sci 47:3496–3504

    Article  PubMed  Google Scholar 

  6. Lohela M, Bry M, Tammela T, Alitalo K (2009) VEGFs and receptors involved in angiogenesis versus lymphangiogenesis. Curr Opin Cell Biol 21:154–165

    Article  PubMed  CAS  Google Scholar 

  7. Reich SJ, Fosnot J, Kuroki A, Tang W, Yang X, Maguire AM, Bennett J, Tolentino MJ (2003) Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model. Mol Vis 9:210–216

    PubMed  CAS  Google Scholar 

  8. Luttun A, Autiero M, Tjwa M, Carmeliet P (2004) Genetic dissection of tumor angiogenesis: are PlGF and VEGFR-1 novel anti-cancer targets? Biochim Biophys Acta 1654:79–94

    PubMed  CAS  Google Scholar 

  9. Rakic JM, Lambert V, Devy L, Luttun A, Carmeliet P, Claes C, Nguyen L, Foidart J, Noel A, Munaut C (2003) Placental growth factor, a member of the VEGF family, contributes to the development of choroidal neovascularization. Invest Ophthalmol Vis Sci 44:3186–3193

    Article  PubMed  Google Scholar 

  10. Nagy JA, Dvorak AM, Dvorak HF (2003) VEGF-A164/165 and PlGF. Roles in angiogenesis and arteriogenesis. Trends Cardiovasc Med 13:169–175

    Article  PubMed  CAS  Google Scholar 

  11. Michels S, Schmidt-Erfurth U, Rosenfeld PJ (2006) Promising new treatments for neovascular age-related macular degeneration. Expert Opin Investig Drugs 15:779–793

    Article  PubMed  CAS  Google Scholar 

  12. Cao Y (2009) Positive and negative modulation of angiogenesis by VEGFR1 ligands. Sci Signal 2:1–11

    Google Scholar 

  13. Adini A, Kornaga T, Firoozbakht F, Benjamin LE (2002) Placental growth factor is a survival factor for tumor endothelial cells and macrophages. Cancer Res 62:2749–2752

    PubMed  CAS  Google Scholar 

  14. Schlingemann RO (2004) Role of growth factors and the wound healing response in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 242:91–101

    Article  PubMed  CAS  Google Scholar 

  15. Shyu KG, Hung HF, Wang BW, Chang H (2008) Hyperbaric oxygen induces placental growth factor expression in bone marrow-derived mesenchymal stem cells. Life Sci 83:65–73

    Article  PubMed  CAS  Google Scholar 

  16. Hu J, Bok D (2001) A cell culture medium that supports the differentiation of human retinal pigment epithelium into functionally polarized monolayers. Mol Vis 7:14–19

    PubMed  CAS  Google Scholar 

  17. Engelmann K, Valtink M (2004) RPE cell cultivation. Graefes Arch Clin Exp Ophthalmol 242:65–67

    Article  PubMed  Google Scholar 

  18. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Webwr K, Tuschl T (2001) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411:494–498

    Article  PubMed  CAS  Google Scholar 

  19. Zuker M (2003) Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res 31:3406–3415

    Article  PubMed  CAS  Google Scholar 

  20. Schmittgen T D, Livak KJ (2008) Analyzing real-time PCR data by the comparative CT method. Nat Protoc 3:1101–1108

    Article  PubMed  CAS  Google Scholar 

  21. Reddy LS, Sarojamma V, Ramakrishna V (2006) RNAi in medicine: current and future perspectives. Biotechnol Mol Biol Rev 1:103–114

    Google Scholar 

  22. Pieramici DJ, Rabena MD (2008) Anti-VEGF therapy: comparison of current and future agents. Eye 22:1330–1336

    Article  PubMed  CAS  Google Scholar 

  23. Distler JHW, Jüngel A, Kurowska-Stolarska M, Michel BA, Gay RE, Gay S, Distler O (2005) Nucleofection: a new, highly efficient transfection method for primary human keratinocytes. Exp Dermatol 14:315–320

    Article  PubMed  Google Scholar 

  24. Cai H, Del Priore LV (2006) Gene expression profile of cultured adult compared to immortalized human retinal pigment epithelium. Mol Vis 12:1–14

    PubMed  CAS  Google Scholar 

  25. Weleber RG (2005) Inherited and orphan retinal diseases: phenotypes, genotypes, and probable treatment groups. Retina 25:54–57

    Article  Google Scholar 

  26. Kanuga N, Winton HL, Beauche’ne L, Koman A, Zerbib A, Halford S, Couraud P, Keegan D, Coffey P, Lund RD, Adamson P, Greenwood J (2002) Characterization of genetically modified human retinal pigment epithelial cells developed for in vitro and transplantation studies. Invest Ophthalmol Vis Sci 43:546–555

    PubMed  Google Scholar 

  27. Ohno-Matsui K, Mori K, Ichinose S, Sato T, Wang J, Shimada N, Kojima A, Mochizuki M, Morita I (2006) In vitro and in vivo characterization of iris pigment epithelial cells cultured on amniotic membranes. Mol Vis 12:1022–1032

    PubMed  CAS  Google Scholar 

  28. Kamba T, McDonald MD (2007) Mechanisms of adverse effects of anti-VEGF therapy for cancer. Br J Cancer 96:1788–1795

    Article  PubMed  CAS  Google Scholar 

  29. Enseleit F, Michels S, Ruschitzka F (2010) Anti-VEGF therapies and blood pressure: more than meets the eye. Curr Hypertens Rep 12:33–38

    Article  PubMed  CAS  Google Scholar 

  30. Michels S, Rosenfeld PJ, Puliafito CA, Marcus EN, Venkatraman AS (2005) Systemic bevacizumab (avastin) therapy for neovascular age-related macular degeneration: twelve-week results of an uncontrolled open-label clinical study. Ophthalmology 112:1035–1047

    Article  PubMed  Google Scholar 

  31. Staton CA, Stribbling SM, Tazzyman S, Hughes R, Brown NJ, Lewis CE (2004) Current methods for assaying angiogenesis in vitro and in vivo. Int J Exp Pathol 85:233–248

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by National Institute of Genetic Engineering and Biotechnology (NIGEB) through grant no.253. Our gratitude and sincere thanks to Zahra Ataei, Pezhman Fahim, Ali Talebian, Ahmad Gharabaghian, and Tahere Chamani for their contribution in completing this work.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Zahra-Soheila Soheili.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Akrami, H., Soheili, ZS., Sadeghizadeh, M. et al. PlGF gene knockdown in human retinal pigment epithelial cells. Graefes Arch Clin Exp Ophthalmol 249, 537–546 (2011). https://doi.org/10.1007/s00417-010-1567-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-010-1567-7

Keywords

Navigation